Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
04/2012
04/19/2012US20120093841 Her2 DNA Vaccine as Adjunct Treatment for Cancers in Companion Animals
04/19/2012US20120093840 Targeted delivery of factor viii proteins to platelets
04/19/2012US20120093837 Compositions and methods for detecting egfr in cancer
04/19/2012US20120093835 Anti-inflammatory antibodies and uses therefor
04/19/2012US20120093833 Human Oncostatin M Antibodies and Methods of Use
04/19/2012US20120093830 Single domain antibodies that bind il-13
04/19/2012US20120093826 Fully human antibodies specific to cadm1
04/19/2012US20120093825 Method for producing antibody using "naked" expression vector expressing type ii transmembrane fusion protein
04/19/2012US20120093822 Dopamine d2 receptor-disc1 interaction, compositions and methods for modulating same
04/19/2012US20120093821 Papillomavirus-like particles (vlp) as broad spectrum human papillomavirus (hpv) vaccines
04/19/2012US20120093811 Anti-vegf-d antibodies
04/19/2012US20120093810 Monoclonal antibody capable of binding to specific discontinuous epitope occurring in ad1 region of human cytomegalovirus gb glycoprotein, and antigen-binding fragment thereof
04/19/2012US20120093808 Humanized pcrv antibody having anti-pseudomonal activity
04/19/2012US20120093805 Anti-cd27 humanized monoclonal antibody
04/19/2012US20120093796 Novel use of ec-sod and method for preparing thereof
04/19/2012US20120093788 Protease for wound conditioning and skin care
04/19/2012US20120093787 Methods and compositions for inhibiting viral entry into cells
04/19/2012US20120093785 Human artificial chromosome (hac) vector
04/19/2012US20120093778 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
04/19/2012US20120093777 Compositions comprising viruses and methods for concentrating virus preparations
04/19/2012US20120093775 Methods and compositions for the treatment of cirrhosis and liver fibrosis
04/19/2012US20120093773 Compositions for Bacterial Mediated Gene Silencing and Methods of Using Same
04/19/2012US20120093772 Vectors for delivery of light sensitive proteins and methods of use
04/19/2012US20120093768 Anti-connexin compounds targeted to connexins and methods of use thereof
04/19/2012US20120093761 Vaccine compositions and methods of use thereof
04/19/2012CA2816156A1 Methods for altering the reactivity of plant cell walls
04/19/2012CA2814713A1 Cardiac induced pluripotent stem cells and methods of use in repair and regeneration of myocardium
04/19/2012CA2814698A1 Compositions and methods for treating endocrine, gastrointestinal or autoimmune disorders
04/19/2012CA2814673A1 Immunoreactive antigens of mycoplasma heamofelis and diagnostic immunoassay
04/19/2012CA2814652A1 Human oncostatin m antibodies and methods of use
04/19/2012CA2814643A1 Recombinant vaccinia virus having hemagglutinin protein genes derived from novel influenza viruses
04/19/2012CA2814591A1 Als inhibitor herbicide tolerant beta vulgaris mutants
04/19/2012CA2814532A1 Soybean plant and seed corresponding to transgenic event mon87712 and methods for detection thereof
04/19/2012CA2814386A1 Antigen delivery platforms
04/19/2012CA2814175A1 Norovirus capsid and rotavirus vp6 protein for use as combined vaccine
04/19/2012CA2814143A1 Methods and compositions for treating hemophilia b
04/19/2012CA2814076A1 Nucleic acid modulators of clec-2
04/19/2012CA2813163A1 Prophylactic or therapeutic agent for fibrosis
04/19/2012CA2812917A1 Production of plants having improved water-deficit tolerance
04/19/2012CA2812833A1 Production of plants with improved tolerance to water deficit
04/19/2012CA2812791A1 Chimeric spider silk and uses thereof
04/19/2012CA2812763A1 Producing alpha-olefins using polyketide synthases
04/19/2012CA2799442A1 Bacterial ribonucleic acid cell wall compositions and methods of making and using them
04/18/2012EP2441844A1 Plants having enhanced yield-related traits and a method for making the same
04/18/2012EP2441843A1 Production of arachidonic acid in oilseed plants
04/18/2012EP2441842A1 Production of arachidonic acid in oilseed plants
04/18/2012EP2441841A2 Increased seed size and seed number through transgenic over expression of a growth and/or development related gene during early embryo development
04/18/2012EP2441840A1 Mucosal or enteral administration of biologically active macromolecules
04/18/2012EP2441839A1 Plants with reduced expression of REVOLUTA (REV) having enhanced yield-related traits and a method for making the same
04/18/2012EP2441838A2 Fusion proteins that contain natural junctions
04/18/2012EP2441837A1 dsRNA compositions and methods for treating HPV infections
04/18/2012EP2441836A1 Compound inhibiting TP53INP1 activity for the treatment of prostate cancer, and its use in screening and diagnostic methods
04/18/2012EP2441835A1 Modulation of stat 6 expression for the treatment of airway hyperresponsiveness
04/18/2012EP2441834A1 Differentially Fluorescent Yeast Biosensors for the Detection and Biodegration of Chemical Agents
04/18/2012EP2441833A1 Aptamer for chymase, and use thereof
04/18/2012EP2441832A1 Novel protein and gene that codes therefor
04/18/2012EP2441831A1 Process for production of protein
04/18/2012EP2441828A1 Algal bio-flocculation by inactivation of photoreceptors
04/18/2012EP2441776A1 Generation of multifunctional and multivalent polypeptide complexes with collagen XVIII trimerization domain
04/18/2012EP2441773A1 Plants having enhanced yield-related traits and a method for making the same
04/18/2012EP2441449A1 Modulation of apolipoprotein C-III expression
04/18/2012EP2440676A2 Inhibition-based high-throughput screen strategy for cell clones
04/18/2012EP2440675A1 Methods for molecular detection
04/18/2012EP2440673A2 Method, compositions and devices for controlling a chemical reaction by pressure, using high-pressure optimized biocomponents
04/18/2012EP2440667A1 Methods and kits for regulating intracellular trafficking of a target protein
04/18/2012EP2440666A1 Virus induced gene silencing (vigs) for functional analysis of genes in cotton.
04/18/2012EP2440665A1 Production of plants with reduced lignin content
04/18/2012EP2440664A1 Drought tolerant plants
04/18/2012EP2440663A1 Early endosperm promoter and methods of use
04/18/2012EP2440662A2 Novel fatty acid elongation components and uses thereof
04/18/2012EP2440661A1 Hmo synthesis
04/18/2012EP2440660A2 Methods, systems, and compositions for neuronal differentiation of multipotent stromal cells
04/18/2012EP2440659A1 Method for dna double-strand break repair in vitro and applications thereof
04/18/2012EP2440582A2 Antigen-norovirus p-domain monomers and dimers, antigen-norovirus p-particle molecules, and methods for their making and use
04/18/2012EP2440581A1 Fusion proteins for delivery of gdnf and bdnf to the central nervous system
04/18/2012EP2440575A1 Identification, optimization and use of shared hla-b*0702 epitopes for immunotherapy
04/18/2012EP2440570A2 Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles
04/18/2012EP2440566A1 CHEMICAL MODIFICATION MOTIFS FOR miRNA INHIBITORS AND MIMETICS
04/18/2012EP2440241A1 Growth hormone polypeptides and methods of making and using same
04/18/2012EP2440233A1 Sorcs1-like agent for use in the treatment of insulin resistance and diseases related thereto
04/18/2012EP2440228A1 Glucose-regulating polypeptides and methods of making and using same
04/18/2012EP2440226A1 Vaccine therapy for choroidal neovascularization
04/18/2012EP2440215A1 New potent anti apob antisense compounds
04/18/2012EP2440214A2 Methods for treating chronic kidney disease
04/18/2012EP2440035A1 A method for the transient expression of nucleic acids in plants
04/18/2012EP2440034A1 High oil content plants
04/18/2012EP2440033A2 Isolated polynucleotides and polypeptides, and methods of using same for increasing nitrogen use efficiency, yield, growth rate, vigor, biomass, oil content, and/or abiotic stress tolerance
04/18/2012EP2209899B1 Zymomonas with improved ethanol production in medium containing concentrated sugars and acetate
04/18/2012EP2176411B1 Nanoparticle-mediated treatment for inflammatory diseases
04/18/2012EP2121933B1 Use of alanine racemase genes to confer nematode resistance to plants
04/18/2012EP2084280B1 Integrated microfluidic component for purifying analyte molecules and purification method
04/18/2012EP2064233B1 Method of increasing resistance against soybean rust in transgenic plants
04/18/2012EP2017332B1 Microorganism capable of producing l-amino acid, and process for production of l-amino acid
04/18/2012EP1794296B1 Subtilases
04/18/2012EP1723233B1 Method for enriching and/or separating prokaryotic dna using a protein that specifically bonds to unmethylated dna containing cpg-motives
04/18/2012EP1718677B1 Monovalent antibody fragments useful as therapeutics
04/18/2012EP1694832B1 Use of a cytochrome p450 gene from nicotiana
04/18/2012EP1676860B1 Process for producing antithrombin III composition
04/18/2012EP1654361B1 Methods and compositions for preparing rna from a fixed sample
04/18/2012EP1650296B1 Mutant serine acetyltransferase and process for producing l-cysteine
1 ... 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 ... 4023